Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vical melanoma drug gets positive safety review
Yahoo/AP
Monday, December 28, 2009 - 10:14am
tags:
Vical, melanoma, Allovectin-7
Cell Therapeutics adopts 'poison pill' plan
Yahoo/AP
Monday, December 28, 2009 - 10:13am
tags:
poison pill, Cell Therapeutics, FDA, cancer, pixantrone
Merck Ends deal with Arena
Yahoo/Zacks.com
Monday, December 28, 2009 - 10:07am
tags:
Arena Pharmaceuticals, obesity, Merck, atherosclerosis, Orexigen
Generics chafe under big pharma's US reform shadow
Guardian/Reuters
Monday, December 28, 2009 - 6:04am
tags:
generics, healthcare reform, biogenerics
The genetic revolution takes aim at the pipeline
Fierce Biotech
Monday, December 28, 2009 - 5:03am
tags:
sequencing, personalized medicine, R&D, Knome, Pacific Biosciences, Complete Genomics
Matthew Herper And Robert Langreth On The Pharmaceutical Industry: in 2010, a major drug company will break up
Forbes
Monday, December 28, 2009 - 4:59am
tags:
JNJ, Medtronic, Pfizer, Vytorin, Boehringer Ingelheim, Elan, Eli Lilly, Fate Therapeutics, Gilead Sciences, Merck, Schering Plough, Wyeth
Drug firms seeking panacea / Many shifting focus to emerging economies in struggle to stay afloat
iStockAnalyst
Monday, December 28, 2009 - 4:55am
tags:
Japan, China, India
Isis Pharma receives US$ 10 mn from OncoGenex' license of OGX-O11 to Teva
Pharmabiz
Monday, December 28, 2009 - 4:51am
tags:
Isis Pharmaceuticals, Teva Pharmaceuticals, licensing, antisense, OncoGenex
Pharma front-and-center on healthcare reform
Fierce Pharma
Monday, December 28, 2009 - 4:48am
tags:
healthcare reform
Large-Cap Biotechs Face Familiar Problem
Yahoo/Investors Business Daily
Monday, December 28, 2009 - 4:45am
tags:
biotech, Amgen, Biogen Idec, Bristol-Myers Squibb, Roche, Genzyme, Gilead Sciences, Celgene
Teva joint venture buys stake in Japan drugmaker
Yahoo/AP
Monday, December 28, 2009 - 4:44am
tags:
Teva Pharmaceuticals, M&A, Japan, Taisho
SEC: Men Made ‘Illicit Profits’ in Sanofi-Chattem Deal
WSJ Online
Monday, December 28, 2009 - 4:43am
tags:
Sanofi, Chattem, M&A, SEC
MedImmune responds to FDA on pediatric drug
Bizjournals.com
Monday, December 28, 2009 - 4:41am
tags:
FDA, MedImmune, Synagis, RSV
The 5 Worst Drug Companies of 2009
BNET Pharma
Monday, December 28, 2009 - 4:40am
tags:
Mylan, Elan, Genzyme, Sequenom, Ranbaxy
Sanofi Said to Drop Bid for German Generics Maker Ratiopharm
Bloomberg
Monday, December 28, 2009 - 4:39am
tags:
generics, Sanofi, Ratiopharm, M&A
CompuGen-Pfizer Deal: What Biotech 'Dreamers' Can Accomplish
Seeking Alpha
Monday, December 28, 2009 - 4:38am
tags:
Pfizer, CompuGen, partnerships
Lilly Prepares for Patent Loss in Psychosis Drug, Moves into Arthritis Market
Seeking Alpha
Monday, December 28, 2009 - 4:36am
tags:
Eli Lilly, arthritis, patents, generics, Incyte, Zyprexa
Pfizer's Lyrica for GAD Rejected by FDA
TheStreet.com
Monday, December 28, 2009 - 4:35am
tags:
GAD, generalized anxiety disorder, Pfizer, FDA, Lyrica
Bristol-Myers lowers 2009 outlook after Mead deal
Yahoo/Reuters
Wednesday, December 23, 2009 - 9:54am
tags:
Mead Johnson, outlook, Bristol-Myers Squibb
Cephalon hikes Provigil price to push new med
Fierce Pharma
Wednesday, December 23, 2009 - 8:54am
tags:
Cephalon, drug pricing, Provigil, jet lag

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.